Inverness Counsel Has Raised Position in Verizon Comm (VZ) by $4.34 Million; Recro Pharma Com (REPH) Stock Value Rose While Essex Investment Management Co Trimmed Position

Recro Pharma, Inc. (NASDAQ:REPH) Logo

Essex Investment Management Co Llc decreased its stake in Recro Pharma Inc Com (REPH) by 15.3% based on its latest 2019Q2 regulatory filing with the SEC. Essex Investment Management Co Llc sold 38,462 shares as the company’s stock rose 5.96% . The hedge fund held 213,002 shares of the health care company at the end of 2019Q2, valued at $2.17 million, down from 251,464 at the end of the previous reported quarter. Essex Investment Management Co Llc who had been investing in Recro Pharma Inc Com for a number of months, seems to be less bullish one the $379.26 million market cap company. The stock decreased 1.10% or $0.19 during the last trading session, reaching $16.68. About 95,628 shares traded. Recro Pharma, Inc. (NASDAQ:REPH) has risen 88.61% since December 4, 2018 and is uptrending. It has outperformed by 88.61% the S&P500. Some Historical REPH News: 24/05/2018 – RECRO PHARMA INC – RECEIVED CRL FROM FDA OFFICE OF DRUG EVALUATION Il REGARDING NEW DRUG APPLICATION (NDA) FOR IV MELOXICAM; 24/05/2018 – Recro Pharma to Request a Meeting With the FDA as Soon as Possible; 27/03/2018 – Recro Pharma Announces Publication of Phase III IV Meloxicam Bunionectomy Data in the Clinical Journal of Pain; 27/03/2018 – Recro Pharma: Data Shows IV Meloxicam Provides Rapid and Sustained Pain Relief Following Bunionectomy Surgery; 15/05/2018 – Millennium Management Buys New 1.4% Position in Recro Pharma; 24/05/2018 – RECRO: CRL RAISED CMC RELATED QUESTIONS ON EXTRACTABLE; 24/05/2018 – Recro Pharma Will Request a Meeting With FDA to Discuss CRL’s Points; 09/05/2018 – Recro Pharma Backs FY18 Guidance of CDMO Revenue of About $70M; 24/05/2018 – Recro Pharma: CRL Raised CMC Related Questions on Extractable and Leachable Data Provided in the NDA; 27/03/2018 Recro Pharma Announces Publication of Phase lll IV Meloxicam Bunionectomy Data in the Clinical Journal of Pain

Inverness Counsel Llc increased its stake in Verizon Comm (VZ) by 18.57% based on its latest 2019Q2 regulatory filing with the SEC. Inverness Counsel Llc bought 76,093 shares as the company’s stock declined 2.21% . The institutional investor held 485,846 shares of the telecommunications equipment company at the end of 2019Q2, valued at $27.76 million, up from 409,753 at the end of the previous reported quarter. Inverness Counsel Llc who had been investing in Verizon Comm for a number of months, seems to be bullish on the $250.50 billion market cap company. The stock increased 0.71% or $0.43 during the last trading session, reaching $60.57. About 5.78 million shares traded. Verizon Communications Inc. (NYSE:VZ) has risen 5.30% since December 4, 2018 and is uptrending. It has outperformed by 5.30% the S&P500. Some Historical VZ News: 11/05/2018 – Cusick added that Verizon has no plan to establish its own video streaming platform but it plans to announce a partnership soon; 05/04/2018 – Verizon takes industry lead in working with key partners to drive advancements on CBRS spectrum; 04/05/2018 – VERIZON COMMUNICATIONS FILES FOR NOTES OFFER VIA BNPP, DB; 24/04/2018 – Verizon 1Q Wireless Retail Customers 116.2M; 13/03/2018 – “While it does not enjoy the scale economics of AT&T and Verizon, it enjoys the advantage of having the superior position of growth as it takes continuous share,” McCormack wrote; 24/04/2018 – Verizon first-quarter results beat estimates; 12/03/2018 – Data breach victims can sue Yahoo in the United States -judge; 06/03/2018 – LAUNCH: Verizon $1.182b+ Device Payment Plan ABS; 05/04/2018 – Oath and Verizon Have Taken Ownership Stake in MoviePass Through Equity in HMNY in Connection With Transaction; 23/04/2018 – Telecoms Slightly Higher Before Verizon Earnings — Telecoms Roundup

Essex Investment Management Co Llc, which manages about $740.27M and $728.65M US Long portfolio, upped its stake in Fulgent Genetics Inc Com by 64,573 shares to 154,801 shares, valued at $1.03M in 2019Q2, according to the filing. It also increased its holding in Amazon Com Inc Com (NASDAQ:AMZN) by 1,621 shares in the quarter, for a total of 9,078 shares, and has risen its stake in Akamai Technologies Inc Com (NASDAQ:AKAM).

Analysts await Recro Pharma, Inc. (NASDAQ:REPH) to report earnings on February, 18. They expect $-0.14 earnings per share, up 75.86% or $0.44 from last year’s $-0.58 per share. After $-0.19 actual earnings per share reported by Recro Pharma, Inc. for the previous quarter, Wall Street now forecasts -26.32% EPS growth.

Investors sentiment increased to 2.09 in 2019 Q2. Its up 0.74, from 1.35 in 2019Q1. It improved, as 7 investors sold REPH shares while 16 reduced holdings. 21 funds opened positions while 27 raised stakes. 12.10 million shares or 8.99% more from 11.11 million shares in 2019Q1 were reported. Chicago Equity Partners Limited Liability Company invested 0.03% of its portfolio in Recro Pharma, Inc. (NASDAQ:REPH). 213,002 were reported by Essex Inv Mngmt Llc. The California-based Parallax Volatility Advisers LP has invested 0% in Recro Pharma, Inc. (NASDAQ:REPH). Goldman Sachs Grp holds 0% or 100,573 shares. Broadfin Limited Liability Company holds 3.46% of its portfolio in Recro Pharma, Inc. (NASDAQ:REPH) for 1.56M shares. Cadence Capital Mngmt Limited Com has 0.13% invested in Recro Pharma, Inc. (NASDAQ:REPH). Barclays Public Limited Co holds 18,948 shares or 0% of its portfolio. Federated Invsts Inc Pa has 1,176 shares for 0% of their portfolio. 14,972 are owned by Voloridge Investment Mngmt Ltd Limited Liability Company. 38,989 were accumulated by Campbell And Adviser Llc. Opus Point Prtn Management Ltd Llc accumulated 11,353 shares. Bnp Paribas Arbitrage Sa holds 2,020 shares. Massachusetts-based Panagora Asset has invested 0.02% in Recro Pharma, Inc. (NASDAQ:REPH). Susquehanna Intll Gp Ltd Liability Partnership has 0% invested in Recro Pharma, Inc. (NASDAQ:REPH) for 10,893 shares. Ny State Common Retirement Fund has invested 0% of its portfolio in Recro Pharma, Inc. (NASDAQ:REPH).

More notable recent Recro Pharma, Inc. (NASDAQ:REPH) news were published by: Benzinga.com which released: “The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera’s Reverse Split, 2 Biotechs To Debut – Benzinga” on November 08, 2019, also Globenewswire.com with their article: “Recro Pharma Announces Effectiveness of Baudax Bio Form 10 Registration Statement – GlobeNewswire” published on November 13, 2019, Streetinsider.com published: “Recro Pharma (REPH) Board of Directors Approves Separation of Acute Care Business Segment and Declares Special Dividend Distribution of Baudax Bio (BXRX) Common Stock – StreetInsider.com” on November 05, 2019. More interesting news about Recro Pharma, Inc. (NASDAQ:REPH) were released by: Benzinga.com and their article: “Stocks That Hit 52-Week Highs On Wednesday – Benzinga” published on November 13, 2019 as well as Nasdaq.com‘s news article titled: “Broadridge Financial Solutions (BR) Misses Q1 Earnings and Revenue Estimates – Nasdaq” with publication date: November 06, 2019.

More notable recent Verizon Communications Inc. (NYSE:VZ) news were published by: Globenewswire.com which released: “Verizon holds sellside analyst meeting in New York on November 19 – GlobeNewswire” on November 19, 2019, also Globenewswire.com with their article: “Verizon to redeem select Verizon InterNotes® due 2028-2029 NYSE:VZ – GlobeNewswire” published on November 15, 2019, Investorplace.com published: “The Good and the Bad About Verizon Stock – Investorplace.com” on November 12, 2019. More interesting news about Verizon Communications Inc. (NYSE:VZ) were released by: Fool.com and their article: “3 Dividend Stocks to Buy on Sale – The Motley Fool” published on November 24, 2019 as well as Globenewswire.com‘s news article titled: “Verizon 5G Ultra Wideband service available in Boston – GlobeNewswire” with publication date: November 19, 2019.

Inverness Counsel Llc, which manages about $2.49B and $1.96B US Long portfolio, decreased its stake in Progressive Corp (NYSE:PGR) by 176,998 shares to 536,299 shares, valued at $42.87M in 2019Q2, according to the filing. It also reduced its holding in Teleflex Inc (NYSE:TFX) by 2,636 shares in the quarter, leaving it with 21,496 shares, and cut its stake in Carlisle Cos. (NYSE:CSL).

Verizon Communications Inc. (NYSE:VZ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.